Pienta KJ - Search Results

1

Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.

Udager AM, Shi Y, Tomlins SA, Alva A, Siddiqui J, Cao X, Pienta KJ, Jiang H, Chinnaiyan AM, Mehra R. Udager AM, et al. Among authors: pienta kj. Prostate. 2014 Sep;74(12):1199-208. doi: 10.1002/pros.22836. Epub 2014 Jul 7. Prostate. 2014. PMID: 25043157 Free PMC article.

2

A common set of nuclear matrix proteins in prostate cancer cells.

Pienta KJ, Lehr JE. Pienta KJ, et al. Prostate. 1993;23(1):61-7. doi: 10.1002/pros.2990230106. Prostate. 1993. PMID: 8337186

3

The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer.

Smith DC, Pienta KJ. Smith DC, et al. Among authors: pienta kj. Urol Clin North Am. 1997 May;24(2):433-7. doi: 10.1016/s0094-0143(05)70390-6. Urol Clin North Am. 1997. PMID: 9126241

4

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: pienta kj. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

5

Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, Pienta KJ. Rubin MA, et al. Among authors: pienta kj. Clin Cancer Res. 2000 Mar;6(3):1038-45. Clin Cancer Res. 2000. PMID: 10741732

6

Decreased galectin-3 expression in prostate cancer.

Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V, Cooper CR. Pacis RA, et al. Among authors: pienta kj. Prostate. 2000 Jul 1;44(2):118-23. doi: 10.1002/1097-0045(20000701)44:2<118::aid-pros4>3.0.co;2-u. Prostate. 2000. PMID: 10881021 Free article.

7

Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures.

Schwab TS, Stewart T, Lehr J, Pienta KJ, Rhim JS, Macoska JA. Schwab TS, et al. Among authors: pienta kj. Prostate. 2000 Jul 1;44(2):164-71. doi: 10.1002/1097-0045(20000701)44:2<164::aid-pros9>3.0.co;2-4. Prostate. 2000. PMID: 10881026 Free article.

8

Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental study.

Williams JF, Muenchen HJ, Kamradt JM, Korenchuk S, Pienta KJ. Williams JF, et al. Among authors: pienta kj. Prostate. 2000 Sep 1;44(4):275-8. doi: 10.1002/1097-0045(20000901)44:4<275::aid-pros3>3.0.co;2-9. Prostate. 2000. PMID: 10951491 Free article.

9

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).

Pienta KJ, Fisher EI, Eisenberger MA, Mills GM, Goodwin JW, Jones JA, Dakhil SR, Crawford ED, Hussain MH. Pienta KJ, et al. Prostate. 2001 Mar 1;46(4):257-61. doi: 10.1002/1097-0045(20010301)46:4<257::aid-pros1031>3.0.co;2-4. Prostate. 2001. PMID: 11241547 Free article. Clinical Trial.

10

VCaP, a cell-based model system of human prostate cancer.

Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R, Lin DL, Pienta KJ. Korenchuk S, et al. Among authors: pienta kj. In Vivo. 2001 Mar-Apr;15(2):163-8. In Vivo. 2001. PMID: 11317522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters